Obligations de TAK
Voici la liste des obligations d'entreprise de Takeda Pharmaceutical Company Limited . Les investisseurs optent souvent pour les obligations d'une société en raison de leur stabilité accrue en période de volatilité du marché. Étudiez les prix, les rendements et d'autres statistiques et trouvez un investissement fiable.
Symbole | YTM % | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
|---|---|---|---|---|---|---|---|---|
 TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 | 5,40% | 107,75% | 5,80% | 2064-07-05 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 | 5,28% | 106,20% | 5,65% | 2054-07-05 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,17% | 101,07% | 5,25% | 2045-06-23 | 500,407 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
| TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 | 5,16% | 106,40% | 5,65% | 2044-07-05 | 800 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 | 4,91% | 72,59% | 3,18% | 2050-07-09 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 | 4,90% | 78,58% | 3,03% | 2040-07-09 | 1,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 | 4,86% | 71,57% | 3,38% | 2060-07-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 | 4,69% | 104,85% | 5,30% | 2034-07-05 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,53% | 99,48% | 4,00% | 2025-06-23 | 800,169 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
| TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 4,29% | 102,75% | 5,00% | 2028-11-26 | 1,727 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 | 4,24% | 89,18% | 2,05% | 2030-03-31 | 2,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,03% | 98,40% | 3,20% | 2026-09-23 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Shire Acquisitions Investments Ireland DAC |
| TKDBTAKEDA PHARMA. 20/40 | 3,72% | 78,94% | 2,00% | 2040-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734964TAKEDA PHARMA. 20/32 | 3,20% | 87,31% | 1,38% | 2032-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344939TAKEDA PHARMA.18/30 REGS | 3,13% | 99,25% | 3,00% | 2030-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734859TAKEDA PHARMA. 20/29 | 2,97% | 91,18% | 1,00% | 2029-07-09 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344912TAKEDA PHARMA. 18/26 REGS | 2,93% | 98,56% | 2,25% | 2026-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734832TAKEDA PHARMA. 20/27 | 2,85% | 94,35% | 0,75% | 2027-07-09 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 0,96% | 116,57% | 5,00% | 2028-11-26 | 22,685 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | 4,00% | 2025-06-23 | 303 K USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
| TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | — | — | 5,00% | 2028-11-26 | 22,685 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |